Pharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pharmaceutical stocks.

Pharmaceutical Stocks Recent News

Date Stock Title
May 8 EBS Looking Into Emergent BioSolutions's Recent Short Interest
May 8 OGN Organon Q1 Earnings: Does The $1 Billion Debt Offering Signal Trouble?
May 8 VERU Veru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial Strains
May 8 LPCN Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024
May 8 VERU Veru GAAP EPS of -$0.07 misses by $0.01, revenue of $4.14M
May 8 VERU Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
May 8 OGN Organon announces pricing of $1 billion senior notes offering
May 8 OGN Organon Announces Pricing of $1.0 Billion Senior Notes Offering
May 7 OGN Four Reasons Why Organon Stock Is A Good Buy
May 7 VERU Veru Q2 2024 Earnings Preview
May 7 OGN Organon plans to offer $1B in senior notes
May 7 OGN Organon Announces Proposed $1.0 Billion Senior Notes Offering
May 7 ELDN Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
May 7 ELDN Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
May 6 VERU Critical Insights From Veru Analyst Ratings: What You Need To Know
May 5 OGN Organon (NYSE:OGN) Will Pay A Dividend Of $0.28
May 4 OGN Organon First Quarter 2024 Earnings: EPS: US$0.79 (vs US$0.70 in 1Q 2023)
May 2 NKTR Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
May 2 EBS Q1 2024 Emergent BioSolutions Inc Earnings Call
May 2 OGN What Makes Organon (OGN) a New Buy Stock
Pharmaceutical

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags